MEETINGS - Investor Conference on Cardiac Rhythm Management (US) September 1998:
This article was originally published in Clinica
Morgan Stanley's second Investor Conference on Cardiac Rhythm Management will take place on September 29 in New York. The half-day meeting will focus on three areas of the electrophysiology market - congestive heart failure (CHF), atrial fibrillation, ventricular tachycardia (VT) and bradycardia. Topics include the expanding roles for implantable cardioverter defibrillators; new developments in treatment of VT and bradycardia; the role of drug therapy, atrial defibrillators and ablation; and biventricular and left ventricular pacing in CHF. For more information contact Morgan Stanley in the US. Tel: +1 212 761 8408. Fax: +1 212 761 0088.